Lv1
30 积分 2022-03-28 加入
Parkinson disease therapy: current strategies and future research priorities
2个月前
已完结
Immolation of p-Aminobenzyl Ether Linker and Payload Potency and Stability Determine the Cell-Killing Activity of Antibody–Drug Conjugates with Phenol-Containing Payloads
3个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
3个月前
已完结
Recent Advances in the Linkers of Drug Conjugates
3个月前
已完结
Antibody–oligonucleotide conjugates enter the clinic
3个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
4个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
4个月前
已完结
THERAPEUTIC OLIGONUCLEOTIDES, IMPURITIES, DEGRADANTS, AND THEIR CHARACTERIZATION BY MASS SPECTROMETRY
7个月前
已完结
Impurities in Oligonucleotide Drug Substances and Drug Products
7个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
7个月前
已完结
皖公网安备34019202002308
